Press "Enter" to skip to content

New patent for Onyx Therap drug KYPROLIS

0
Copyright © DrugPatentWatch. Originally published at New patent for Onyx Therap drug KYPROLIS

Annual Drug Patent Expirations for KYPROLIS
Annual Drug Patent Expirations for KYPROLIS

Kyprolis is a drug marketed by Onyx Therap and is included in one NDA. There are eleven patents protecting this drug and three Paragraph IV challenges.

Drug patent litigation for KYPROLIS.

This drug has one hundred and ninety-one patent family members in forty-one countries.

The generic ingredient in KYPROLIS is carfilzomib. Additional details are available on the carfilzomib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Onyx Therap drug KYPROLIS
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!